These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15293289

  • 1. Evidence for pathogenic heterogeneity in multiple sclerosis.
    Lucchinetti CF, Bruck W, Lassmann H.
    Ann Neurol; 2004 Aug; 56(2):308. PubMed ID: 15293289
    [No Abstract] [Full Text] [Related]

  • 2. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F, Chojnacki A, Weiss S, Antel JP.
    Adv Neurol; 2006 Aug; 98():47-63. PubMed ID: 16400826
    [No Abstract] [Full Text] [Related]

  • 3. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 4. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
    Vanderlocht J, Hellings N, Hendriks JJ, Vandenabeele F, Moreels M, Buntinx M, Hoekstra D, Antel JP, Stinissen P.
    J Neurosci Res; 2006 Apr 29; 83(5):763-74. PubMed ID: 16477612
    [Abstract] [Full Text] [Related]

  • 5. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S, Dumas M.
    Neurol Clin; 1983 Aug 29; 1(3):729-55. PubMed ID: 6680171
    [Abstract] [Full Text] [Related]

  • 6. Understanding multiple sclerosis: lessons from pathology.
    Ludwin SK.
    Ann Neurol; 2000 Jun 29; 47(6):691-3. PubMed ID: 10852534
    [No Abstract] [Full Text] [Related]

  • 7. Oligodendrocyte apoptosis before immune attack in multiple sclerosis?
    Pender MP.
    Ann Neurol; 2005 Jan 29; 57(1):158; author reply 158-9. PubMed ID: 15622546
    [No Abstract] [Full Text] [Related]

  • 8. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment.
    Antel J.
    Clin Neurol Neurosurg; 2006 Mar 29; 108(3):245-9. PubMed ID: 16384636
    [Abstract] [Full Text] [Related]

  • 9. [Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. I].
    Prick JJ, Jaspar HH.
    Proc K Ned Akad Wet C; 1972 Mar 29; 75(4):257-75. PubMed ID: 4263755
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. II].
    Prick JJ, Jaspar HH.
    Proc K Ned Akad Wet C; 1972 Mar 29; 75(4):276-86. PubMed ID: 4263756
    [No Abstract] [Full Text] [Related]

  • 11. Hypersensitivity to myelin protein preceding attacks of multiple sclerosis.
    Sheremata W, Cosgrove JB, Eylar EH.
    Trans Am Neurol Assoc; 1974 Mar 29; 99():177-82. PubMed ID: 4463529
    [No Abstract] [Full Text] [Related]

  • 12. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 29; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 13. Multiple sclerosis: an overview.
    Rose AS.
    Adv Neurol; 1981 Jan 29; 31():3-9. PubMed ID: 7325046
    [No Abstract] [Full Text] [Related]

  • 14. Myelin peptides in multiple sclerosis.
    Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Dàvalos A, Pujol-Borrell R, Borràs FE, Martínez-Cáceres E.
    Autoimmun Rev; 2009 Jul 29; 8(8):650-3. PubMed ID: 19393199
    [Abstract] [Full Text] [Related]

  • 15. Myelin sheath: a new possible role in sleep mechanism.
    Morelli A, Ravera S, Panfoli I.
    Sleep Med; 2011 Feb 29; 12(2):199. PubMed ID: 21276748
    [No Abstract] [Full Text] [Related]

  • 16. Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis.
    Zhang QY, Huang JH, Li HZ, Guo HT, Zhong YQ, Wang YM, Pei JM.
    Arch Med Res; 2008 Jan 29; 39(1):45-51. PubMed ID: 18067995
    [Abstract] [Full Text] [Related]

  • 17. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Falcone M, Scalise A, Minisci C, Romito D, Cancelli I, Gigli GL.
    Neurol Sci; 2006 Apr 29; 27(1):58-62. PubMed ID: 16688601
    [Abstract] [Full Text] [Related]

  • 18. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease.
    Butts BD, Houde C, Mehmet H.
    Cell Death Differ; 2008 Jul 29; 15(7):1178-86. PubMed ID: 18483490
    [Abstract] [Full Text] [Related]

  • 19. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N, Chesik D, Hoekstra D, De Keyser J.
    Neurochem Int; 2008 Jun 29; 52(8):1431-5. PubMed ID: 18471934
    [Abstract] [Full Text] [Related]

  • 20. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.
    Gay FW.
    Clin Neurol Neurosurg; 2006 Mar 29; 108(3):234-40. PubMed ID: 16364541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.